Additionally, more than 95% of encapsulated anti‐cancer drugs that are administered intravenously have been found to accumulate in other organs, introducing unwanted toxicity.[30, 31] Taken together, the field is still lacking a straightforward and effective approach to treat the primary tumor to help prevent metastases by employing soluble TRAIL as a localized therapeutic. This evidence concerns the gene TNFSF10 and cancer.